Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model

Esselen, Katharine

365 - Poster Session B
Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model

Sunday, March 23, 2014: 2:40 PM

West Exhibit Hall (Tampa Convention Center)

K. M. Esselen¹, J. Kim², A. Wright³ and N. S. Horowitz²
¹Brigham and Women's Hospital/Harvard University, Boston, MA, ²Harvard University, Boston, MA, ³Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

365 - Poster Session B
Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model

365 - Poster Session B Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model

365 - Poster Session B
Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model